Cite
HARVARD Citation
Ningarhari, M. et al. (2022). Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach. Hepatology communications. 6 (10), pp. 2964-2974. [Online].